Detection of Intestinal Metaplasia in Barrett's Esophagus: An Observational Comparator Study Suggests the Need for a Minimum of Eight Biopsies

OBJECTIVES:Intestinal metaplasia (IM) and dysplasia in Barrett's esophagus are recognized surrogates for esophageal adenocarcinoma risk. While few would argue with the “hunt for dysplasia,” there is a divide regarding the usefulness of the histological confirmation of intestinal metaplasia in endoscopically apparent long segment Barrett's esophagus. We aimed to assess the frequency of intestinal metaplasia in 125 consecutive patients with columnar-lined esophagus and to determine the optimal biopsy protocol to detect intestinal metaplasia.METHODS:Two-hundred ninety-six endoscopies were performed over a 4-yr period in Barrett's esophagus segments of mean length 4 cm (range 1–11 cm) at a single center and the resulting biopsies were analyzed retrospectively. Biopsies were all processed with routine hematoxylin and eosin (H&E) staining, and a subset (N = 92) was subject to alcian blue/periodic-acid Schiff staining.RESULTS:Using H&E staining, we found that the optimum number of biopsies to diagnose intestinal metaplasia was 8 per endoscopy, mean 67.9% endoscopies having intestinal metaplasia. In contrast, if only four were taken the yield was 34.7% with intestinal metaplasia. Unless more than 16 biopsies were taken (100% yield of intestinal metaplasia), no additional significant detection was achieved. Using additional alcian blue/periodic-acid Schiff staining only had a marginal benefit, with 5.4% of new cases of intestinal metaplasia being identified. There is a proximal cephalo-caudal gradient of intestinal metaplasia, especially with increased chronological age, but doing repeat endoscopies on patients did not increase the detection of intestinal metaplasia.CONCLUSIONS:The data suggest that at least 8 random biopsies is the minimum to be taken and analyzed with conventional H&E staining to diagnose benign intestinal metaplasia. Taking more biopsies did not statistically increase the diagnosis of intestinal metaplasia except when greater than 16 were taken when 100% yield was obtained.

[1]  Gwendolyn R. Goss,et al.  Theory and Practice of Histological Techniques , 2009 .

[2]  Michael Vieth,et al.  The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. , 2006, Gastroenterology.

[3]  S. Spechler,et al.  Intestinal metaplasia at the gastroesophageal junction. , 2004, Gastroenterology.

[4]  R. Sampliner,et al.  Progression or regression of barrett's esophagus—is it all in the eye of the beholder? , 2003, American Journal of Gastroenterology.

[5]  N. Shepherd Barrett’s esophagus: its pathology and neoplastic complications , 2003, Esophagus.

[6]  M. Pera Trends in Incidence and Prevalence of Specialized Intestinal Metaplasia, Barrett’s Esophagus, and Adenocarcinoma of the Gastroesophageal Junction , 2003, World journal of surgery.

[7]  R. Sampliner,et al.  Endoscopic Surveillance of Columnar-Lined Esophagus: Frequency of Intestinal Metaplasia Detection and Impact of Antireflux Surgery , 2003, American Journal of Gastroenterology.

[8]  A. Csendes,et al.  Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia , 2002, American Journal of Gastroenterology.

[9]  T. Demeester,et al.  Distribution and Significance of Epithelial Types in Columnar-Lined Esophagus , 2001, The American journal of surgical pathology.

[10]  J. Peters,et al.  Determinants of intestinal metaplasia within the columnar-lined esophagus. , 2000, Archives of surgery.

[11]  T. Demeester,et al.  Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. , 2000, Annals of surgery.

[12]  D. Kerr,et al.  Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. , 1999, The American journal of pathology.

[13]  Kenneth K Wang,et al.  Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus , 1998, The American Journal of Gastroenterology.

[14]  R. Goyal,et al.  The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. , 1996, Gastroenterology.

[15]  J. Peters,et al.  Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. , 1994, The Journal of thoracic and cardiovascular surgery.

[16]  R. Goyal,et al.  The histologic spectrum of Barrett's esophagus. , 1976, The New England journal of medicine.

[17]  A. Csendes,et al.  Prevalence of intestinal metaplasia according to the length of the specialized columnar epithelium lining the distal esophagus in patients with gastroesophageal reflux. , 2003, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[18]  R. Sampliner,et al.  Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus , 2002, American Journal of Gastroenterology.

[19]  D. Day,et al.  Biopsy pathology of the oesophagus, stomach and duodenum , 1986 .

[20]  J. Cameron,et al.  Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux. , 1985, American journal of surgery.